Jiajun Huang

Jiajun Huang

Auto-generated profile, based on publicly available information

Jiajun Huang

State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2016 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
YLYantao Li
Yantao Li
WLWanjun Lin
Wanjun Lin
JHJiajun Huang
Jiajun Huang
YXYing Xie
Ying Xie
WMWenzhe Ma
Wenzhe Ma
Gynostemma pentaphyllum (Thunb.) Makino (GpM) (Jiaogulan) has been widely used in Chinese medicine for the treatment of several diseases, including hepatitis, diabetes and cardiovascular disease. Furthermore, GpM has recently been shown to exhibit potent anti-cancer activities. In this review, we have summarized recent research progress on the anti-cancer activities and mechanisms of action of GpM, as well as determining the material basis for the anti-cancer effects of GpM by searching the PubMed, Web of Science and China National Knowledge Infrastructure databases. The content of this review is based on studies reported in the literature pertaining to the chemical components or anti-cancer effects of GpM up until the beginning of August, 2016. This search of the literature revealed that more than 230 compounds have been isolated from GpM, and that most of these compounds (189) were saponins, which are also known as gypenosides. All of the remaining compounds were classified as sterols, flavonoids or polysaccharides. Various extracts and fractions of GpM, as well as numerous pure compounds isolated from this herb exhibited inhibitory activity towards the proliferation of cancer cells in vitro and in vivo. Furthermore, the results of several clinical studies have shown that GpM formula could have potential curative effects on cancer. Multiple mechanisms of action have been proposed regarding the anti-cancer activities of GpM, including cell cycle arrest, apoptosis, inhibition of invasion and metastasis, inhibition of glycolysis and immunomodulating activities.

17 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WLWanjun Lin
Wanjun Lin
JHJiajun Huang
Jiajun Huang
ZYZhongwen Yuan
Zhongwen Yuan
SFSenling Feng
Senling Feng
YXYing Xie
Ying Xie
WMWenzhe Ma
Wenzhe Ma
Triple-negative breast cancer (TNBC) is a subtype of breast cancer lacking targeted therapy currently. Recent studies imply that protein kinase C may play important roles in TNBC development and could be a specific target. In this study, we evaluated the anti-proliferative activity of PKC inhibitor chelerythrine on a panel of breast cancer cell lines. Chelerythrine selectively inhibited the growth of TNBC cell lines compared to non-TNBC cell lines as demonstrated by in vitro cell proliferation assay and colony formation assay, as well as evidenced by in vivo xenograft assay. The selective anti-proliferative effect of chelerythrine was associated with induction of apoptosis in TNBC cell lines. We further demonstrated that PKN2, one of the PKC subtypes, was highly expressed in TNBC cell lines, and knocking down PKN2 in TNBC cells inhibited colony formation and xenograft growth. This indicates that PKN2 is required for the survival of TNBC cells, and could be the target mediates the selective activity of chelerythrine. Finally, combination of chelerythrine and chemotherapy reagent taxol showed synergistic/additive effect on TNBC cell lines. Our results suggest chelerythrine or other PKC inhibitors may be promising regimens for TNBC tumors.

27 June 2022 in Talanta
Verified
Journal Article
Closed access
XZXiaoyu Zhao
Xiaoyu Zhao
YHYuxin Huang
Yuxin Huang
XLXiang Li
Xiang Li
WYWeihao Yang
Weihao Yang
YLYaoyi Lv
Yaoyi Lv
Shengli MiShengli Mi
Shengli Mi

30 June 2021 in The Analyst
Verified
Journal Article
Closed access
PDF file
XZXiaoyu Zhao
Xiaoyu Zhao
XLXiang Li
Xiang Li
WYWeihao Yang
Weihao Yang
JPJiwei Peng
Jiwei Peng
JHJiajun Huang
Jiajun Huang
Shengli MiShengli Mi
Shengli Mi
The centrifugal microfluidic detection system employs loop–mediated isothermal amplification (LAMP) assay and provides sample-in-answer-out nucleic acid detection of Human papillomavirus (HPV).

27 April 2021 in PLOS Biology
Verified
Journal Article
Open access
PDF file
JHJiajun Huang
Jiajun Huang
XZXiaoyu Zhao
Xiaoyu Zhao
XLXiang Li
Xiang Li
JPJiwei Peng
Jiwei Peng
WYWeihao Yang
Weihao Yang
Shengli MiShengli Mi
Shengli Mi
Renal cell carcinoma (RCC) is responsible for most cases of the kidney cancer. Previous research showed that low serum levels of cholesterol level positively correlate with poorer RCC-specific survival outcomes. However, the underlying mechanisms and functional significance of the role of cholesterol in the development of RCC remain obscure. 3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) plays a pivotal role in RCC development as it is the key rate-limiting enzyme of the cholesterol biosynthetic pathway. In this study, we demonstrated that the inhibition of HMGCR could accelerate the development of RCC tumors by lactate accumulation and angiogenesis in animal models. We identified that the inhibition of HMGCR led to an increase in glycolysis via the regulated HSP90 expression levels, thus maintaining the levels of a glycolysis rate-limiting enzyme, pyruvate kinase M2 (PKM2). Based on these findings, we reversed the HMGCR inhibition-induced tumor growth acceleration in RCC xenograft mice by suppressing glycolysis. Furthermore, the coadministration of Shikonin, a potent PKM2 inhibitor, reverted the tumor development induced by the HMGCR signaling pathway.

27 May 2021 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
XLXiang Li
Xiang Li
XZXiaoyu Zhao
Xiaoyu Zhao
WYWeihao Yang
Weihao Yang
FXFei Xu
Fei Xu
BCBailiang Chen
Bailiang Chen
Shengli MiShengli Mi
Shengli Mi